![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | C07K 16/22 | |
A61K 39/395 | |||
C07K 14/51 | |||
G01N 33/53 | |||
A61P 19/10 |
(11) | Number of the document | 1636270 |
(13) | Kind of document | T |
(96) | European patent application number | 04776553.2 |
Date of filing the European patent application | 2004-06-15 | |
(97) | Date of publication of the European application | 2006-03-22 |
(45) | Date of publication and mention of the grant of the patent | 2016-07-20 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2004/018912 |
Date | 2004-06-15 |
(87) | Number | WO 2005/014650 |
Date | 2005-02-17 |
(30) | Number | Date | Country code |
478977 P | 2003-06-16 | US |
(72) |
WINKLER, David, G., US
SHI, Jiye, US
LATHAM, John, US
|
(73) |
UCB Pharma S.A.,
Allée de la Recherche 60, 1070 Brussels,
BE
|
(54) | ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION |
ANTIBODIES SPECIFIC FOR SCLEROSTIN AND METHODS FOR INCREASING BONE MINERALIZATION |